AXELIOS 1 Platform*
A new standard in sequencing
Fast and flexible, with groundbreaking scalability – go further with the platform powered by sequencing by expansion (SBX) technology.
*AXELIOS 1 is for Research Use Only. Not for use in diagnostic procedures.
Latest news
Roche earns 2026 IMV ServiceTrak™ Awards
We were recognized with all 9 IMV ServiceTrak™ awards for excellence in Core Lab Customer Satisfaction, System Performance and Service Performance.
FDA clears cobas® BV/CV for fast, accurate vaginitis diagnosis
This molecular diagnostic test provides results for both Bacterial vaginosis (BV) and Candida vaginitis (CV) from a single vaginal swab sample.
Roche appoints Dan Malarek as President and CEO of Roche Diagnostics North America
Malarek succeeds Brad Moore, who retired in July after nearly 10 years with Roche.
Related content
The AXELIOS 1 Platform is engineered to redefine next-generation sequencing (NGS). Powered by sequencing by expansion (SBX) chemistry.
* AXELIOS 1 is for Research Use Only. Not for use in diagnostic procedures.
The AXELIOS 1 Platform is engineered to redefine next-generation sequencing (NGS). Powered by sequencing by expansion (SBX) chemistry.
* AXELIOS 1 is for Research Use Only. Not for use in diagnostic procedures.
Experience simplicity at scale with high-volume clinical chemistry and 2,000 tests per hour
Experience simplicity at scale with high-volume clinical chemistry and 2,000 tests per hour
Related links
Products
Learn more about our portfolio of lab instruments, systems, assays and more
Documents
More than 800,000 documents available on demand — always up-to-date with 24/7 access
